FOXP1 and neoplasm: Our genomic profiling data showed a small deletion at 3p13 targeting the 3 ́-part of FOXP1 which may underlie reduced expression levels in EOL-1 (S5 Fig, S8C and S8D Fig), indicating tumor suppressor activity for this gene.